By Katherine Hamilton
Benitec Biopharma appointed Sophie Mukadam as its chief operating officer and named executive director Megan Boston to its chief financial officer role.
Mukadam will take the post effective Jan. 1 and will receive a base salary of $500,000 and a target annual bonus of 40% of her base salary, according to a Friday filing with the Securities and Exchange Commission.
Mukadam has been serving as Benitec's associate director of program management, starting in May 2021. Before joining the company, she worked as a regulatory consultant. She holds a bachelor's degree from the University of California, Berkeley.
Boston was appointed chief financial officer effective Jan. 1. She was also confirmed as the company's secretary. Boston will continue serving as the principal financial officer and principal accounting officer.
Boston is set to receive $415,000 in annual salary, with a target annual discretionary bonus of 40% of that salary. She has been granted nonqualified stock options to purchase 720,000 shares, according to a filing. The options were granted at an exercise price of $12.18 per share.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
December 13, 2024 17:41 ET (22:41 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。